Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Translational Neurorehabilitation Research in the Third World What Barriers to Trial Participation Can Teach Us

Full text
Author(s):
Anjos, Sarah M. [1] ; Cohen, Leonardo G. [2] ; Sterr, Annette [3] ; de Andrade, Karina N. F. [1] ; Conforto, Adriana B. [4, 1]
Total Authors: 5
Affiliation:
[1] Univ Sao Paulo, Hosp Clin, Neurol Clin Div, Dept Neurol, Sao Paulo - Brazil
[2] NINDS, Human Cort Physiol & Stroke Rehabil Sect, NIH, Bethesda, MD 20892 - USA
[3] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey - England
[4] Hosp Israelita Albert Einstein, Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: STROKE; v. 45, n. 5, p. 1495-1497, MAY 2014.
Web of Science Citations: 9
Abstract

Background and Purpose Most stroke rehabilitation studies have been performed in high-income countries. The aim of this study was to identify the main barriers for patient inclusion in a research protocol performed in Brazil. MethodsWe evaluated reasons for exclusion of patients in a pilot, randomized, double-blinded clinical trial of stroke rehabilitation. Descriptive statistical analysis was performed. ResultsOnly 5.6% of 571 screened patients were included. Recurrent stroke was responsible for exclusion of 45.4% of potentially eligible patients. ConclusionsRecurrent stroke represented a big barrier to enroll patients in the protocol. External validity of rehabilitation trials will benefit from definition of study criteria according to regional characteristics of patients, including rates of recurrent stroke. Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01333579. (AU)